Cargando…
Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease
BACKGROUND: Bladder cancer (BC) patients with advanced disease have poor outcomes. The use of patient‐reported outcomes (PROs) could lead to improvements in symptom management and hence quality of life (QoL). The aim of this study is to report correlations between selected PROs and QoL and thus to p...
Autores principales: | Taarnhøj, Gry A., Johansen, Christoffer, Lindberg, Henriette, Basch, Ethan, Dueck, Amylou, Pappot, Helle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7196058/ https://www.ncbi.nlm.nih.gov/pubmed/32154663 http://dx.doi.org/10.1002/cam4.2958 |
Ejemplares similares
-
Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy
por: Taarnhøj, Gry Assam, et al.
Publicado: (2019) -
Patient-Reported Outcomes, Health-Related Quality of Life, and Clinical Outcomes for Urothelial Cancer Patients Receiving Chemo- or Immunotherapy: A Real-Life Experience
por: Taarnhøj, Gry Assam, et al.
Publicado: (2021) -
Population‐level evidence of survival benefits of patient‐reported outcome symptom monitoring software systems in routine cancer care
por: Basch, Ethan, et al.
Publicado: (2020) -
Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study
por: Taarnhøj, Gry Assam, et al.
Publicado: (2020) -
Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study
por: Omland, Lise H., et al.
Publicado: (2020)